Literature DB >> 11095709

Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis.

P Pasinelli1, M K Houseweart, R H Brown, D W Cleveland.   

Abstract

Familial amyotrophic lateral sclerosis-linked mutations in copper-zinc superoxide dismutase cause motor neuron death through one or more acquired toxic properties. An early event in the mechanism of toxicity from such mutants is now demonstrated to be activation of caspase-1. Neuronal death, however, follows only after months of chronic caspase-1 activation concomitantly with activation of the executioner caspase-3 as the final step in the toxic cascade. Thus, a common toxicity of mutant SOD1 is a sequential activation of at least two caspases, caspase-1 that acts slowly as a chronic initiator and caspase-3 acting as the final effector of cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095709      PMCID: PMC17673          DOI: 10.1073/pnas.240305897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter

Authors: 
Journal:  Nat Neurosci       Date:  1999-09       Impact factor: 24.884

Review 2.  The role of apoptosis in neurodegenerative diseases.

Authors:  P Desjardins; S Ledoux
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

3.  Inhibition of ICE slows ALS in mice.

Authors:  R M Friedlander; R H Brown; V Gagliardini; J Wang; J Yuan
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

4.  Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  S Vukosavic; M Dubois-Dauphin; N Romero; S Przedborski
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

5.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

6.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

7.  Toxic mutants in Charcot's sclerosis.

Authors:  D W Cleveland; N Laing; P V Hurse; R H Brown
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

8.  DNA-fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders.

Authors:  D S Tews; H H Goebel; H M Meinck
Journal:  Acta Neurol Scand       Date:  1997-12       Impact factor: 3.209

9.  Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.

Authors:  J Jordan; G D Ghadge; J H Prehn; P T Toth; R P Roos; R J Miller
Journal:  Mol Pharmacol       Date:  1995-06       Impact factor: 4.436

10.  Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons.

Authors:  X Mu; J He; D W Anderson; J Q Trojanowski; J E Springer
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

View more
  92 in total

1.  Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis.

Authors:  C Guégan; M Vila; G Rosoklija; A P Hays; S Przedborski
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

Review 2.  Programmed cell death in amyotrophic lateral sclerosis.

Authors:  Christelle Guégan; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 3.  Astrocytes in neurodegenerative disease.

Authors:  Hemali Phatnani; Tom Maniatis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-15       Impact factor: 10.005

4.  Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis.

Authors:  Nichole A Reyes; Jill K Fisher; Kathryn Austgen; Scott VandenBerg; Eric J Huang; Scott A Oakes
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

5.  Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.

Authors:  Francesco Paolo Di Giorgio; Monica A Carrasco; Michelle C Siao; Tom Maniatis; Kevin Eggan
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

Review 6.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

7.  Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS.

Authors:  Anika M Helferich; Sarah J Brockmann; Jörg Reinders; Dhruva Deshpande; Karlheinz Holzmann; David Brenner; Peter M Andersen; Susanne Petri; Dietmar R Thal; Jens Michaelis; Markus Otto; Steffen Just; Albert C Ludolph; Karin M Danzer; Axel Freischmidt; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

8.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

Authors:  C Raoul; E Buhler; C Sadeghi; A Jacquier; P Aebischer; B Pettmann; C E Henderson; G Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

Review 9.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.

Authors:  Yi Zhang; Anna Cook; Jinho Kim; Sergei V Baranov; Jiying Jiang; Karen Smith; Kerry Cormier; Erik Bennett; Robert P Browser; Arthur L Day; Diane L Carlisle; Robert J Ferrante; Xin Wang; Robert M Friedlander
Journal:  Neurobiol Dis       Date:  2013-03-26       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.